澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Osteopore

0.010

-0.001-9.09%

成交量：2,021.51万

成交额：21.60万

市值：432.50万

市盈率：-0.33

高：0.012

开：0.011

低：0.010

收：0.011

52周最高：0.048

52周最低：0.006

股本：4.33亿

流通股本：2.08亿

量比：7.60

换手率：9.73%

股息：- -

股息率：- -

每股收益(TTM):-0.030

每股收益(LYR):-0.043

净资产收益率：-487.52%

总资产收益率：-42.76%

市净率：-10.21

市盈率(LYR):-0.23

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Osteopore Ltd达成协议在中国大陆及港澳地区商业化其牙科、正畸及颌面产品

Osteopore与Accelerate Technologies签署独家许可协议，引进新型再生技术

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/OSX.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"OSX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSX.AU\",,,,,undefined,":{"symbol":"OSX.AU","market":"AU","secType":"STK","nameCN":"Osteopore","latestPrice":0.01,"timestamp":1770684727251,"preClose":0.011,"halted":0,"volume":20215078,"delay":0,"changeRate":-0.09090909090909084,"nameEN":"Osteopore","floatShares":207851789,"shares":432501807,"eps":-0.029897,"marketStatus":"交易中","change":-0.001,"latestTime":"02-10 11:54:44 AEDT","open":0.011,"high":0.012,"low":0.01,"amount":216019,"amplitude":0.181818,"askPrice":0.01,"askSize":400074,"bidPrice":0.009,"bidSize":11483775,"shortable":3,"etf":0,"ttmEps":-0.029897,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.011,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":7.598076,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSX.AU\",,,,,undefined,":{"symbol":"OSX.AU","floatShares":207851789,"roa":"-42.76%","roe":"-487.52%","lyrEps":-0.042829,"volumeRatio":7.598076,"shares":432501807,"dividePrice":0,"high":0.012,"amplitude":0.181818,"preClose":0.011,"low":0.01,"week52Low":0.006,"pbRate":"-10.21","psRate":"1.52","week52High":0.048,"institutionHeld":0,"latestPrice":0.01,"committee":0.932669,"eps":-0.029897,"divideRate":0,"volume":20215078,"delay":0,"ttmEps":-0.029897,"open":0.011,"prevYearClose":0.006,"prevWeekClose":0.009,"prevMonthClose":0.015,"prevQuarterClose":0.006,"fiveDayClose":0.012,"twentyDayClose":0.009,"sixtyDayClose":0.01,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-02-23","symbol":"OSX.AU","defaultRemindTime":1708642800000,"type":"split","dateTimestamp":1708606800000,"forFactor":15,"toFactor":1,"ratio":15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1182881983","title":"Osteopore Ltd达成协议 在中国大陆及港澳地区商业化其牙科、正畸及颌面产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1182881983","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182881983?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 05:22","pubTimestamp":1768512155,"startTime":"0","endTime":"0","summary":"Osteopore Ltd宣布已签署一项重要商业协议，旨在将其旗下的牙科、正畸及颌面外科产品线引入中国大陆、香港和澳门市场进行商业化运营。此举标志着该公司在拓展亚太地区业务方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"1110015613","title":"Osteopore与Accelerate Technologies签署独家许可协议，引进新型再生技术","url":"https://stock-news.laohu8.com/highlight/detail?id=1110015613","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110015613?lang=zh_cn&edition=fundamental","pubTime":"2026-01-08 06:22","pubTimestamp":1767824569,"startTime":"0","endTime":"0","summary":"Osteopore有限公司已与Accelerate Technologies私人有限公司达成一项独家技术许可协议，旨在引进并商业化一项创新的再生技术。该协议的签署标志着Osteopore在生物材料和组织工程领域的战略布局进一步深化，有望借助Accelerate Technologies的研发实力，拓展其在医疗再生领域的产品管线。这项合作将为双方带来协同效应，加速新型再生技术的临床应用和市场推广。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OSX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}